This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Advance Care Planning Australia. (2021). Advance care planning explained Austin Health. Retrieved 18 March from https://www.advancecareplanning.org.au/understand-advance-care-planning/advance-care-planning-explainedAdvance Care Planning Australia2021Austin HealthRetrieved 18 March from https://www.advancecareplanning.org.au/understand-advance-care-planning/advance-care-planning-explainedSearch in Google Scholar
Aradi, S. D., & Hauser, R. A. (2020). Medical Management and Prevention of Motor Complications in Parkinson's Disease. Neurotherapeutics, 17(4), 1339–1365. https://doi.org/10.1007/s13311-020-00889-4AradiS. D.HauserR. A.2020Medical Management and Prevention of Motor Complications in Parkinson's Disease17413391365https://doi.org/10.1007/s13311-020-00889-4Search in Google Scholar
Barrachina-Fernández, M., Maitín, A. M., Sánchez-Ávila, C., & Romero, J. P. (2021). Wearable Technology to Detect Motor Fluctuations in Parkinson's Disease Patients: Current State and Challenges. Sensors (Basel), 21(12). https://doi.org/10.3390/s21124188Barrachina-FernándezM.MaitínA. M.Sánchez-ÁvilaC.RomeroJ. P.2021Wearable Technology to Detect Motor Fluctuations in Parkinson's Disease Patients: Current State and Challenges2112https://doi.org/10.3390/s21124188Search in Google Scholar
Barthel, C., Mallia, E., Debu, B., Bloem, B. R., & Ferraye, M. U. (2016). The Practicalities of Assessing Freezing of Gait. Journal of Parkinson's Disease, 6, 667–674. https://doi.org/10.3233/JPD-160927BarthelC.MalliaE.DebuB.BloemB. R.FerrayeM. U.2016The Practicalities of Assessing Freezing of Gait6667674https://doi.org/10.3233/JPD-160927Search in Google Scholar
Beitz, J. M. (2014). Parkinson's disease: a review. Front Biosci (Schol Ed), 6(1), 65–74. https://doi.org/10.2741/s415BeitzJ. M.2014Parkinson's disease: a review616574https://doi.org/10.2741/s415Search in Google Scholar
Bhasin, S. K., & Bharadwaj, I. U. (2021). Perceptions and meanings of living with Parkinson's disease: an account of caregivers lived experiences. International journal of qualitative studies on health and well-being, 16(1), 1967263–1967263. https://doi.org/10.1080/17482631.2021.1967263BhasinS. K.BharadwajI. U.2021Perceptions and meanings of living with Parkinson's disease: an account of caregivers lived experiences16119672631967263https://doi.org/10.1080/17482631.2021.1967263Search in Google Scholar
Bhat, S., Acharya, U. R., Hagiwara, Y., Dadmehr, N., & Adeli, H. (2018). Parkinson's disease: Cause factors, measurable indicators, and early diagnosis. Comput Biol Med, 102, 234–241. https://doi.org/10.1016/j.compbiomed.2018.09.008BhatS.AcharyaU. R.HagiwaraY.DadmehrN.AdeliH.2018Parkinson's disease: Cause factors, measurable indicators, and early diagnosis102234241https://doi.org/10.1016/j.compbiomed.2018.09.008Search in Google Scholar
Borghammer, P., & Van Den Berge, N. (2019). Brain-First versus Gut-First Parkinson's Disease: A Hypothesis. J Parkinsons Dis, 9(s2), S281–s295. https://doi.org/10.3233/jpd-191721BorghammerP.Van Den BergeN.2019Brain-First versus Gut-First Parkinson's Disease: A Hypothesis9s2S281s295https://doi.org/10.3233/jpd-191721Search in Google Scholar
Carbone, F., Djamshidian, A., Seppi, K., & Poewe, W. (2019). Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs, 33(9), 905–918. https://doi.org/10.1007/s40263-019-00661-zCarboneF.DjamshidianA.SeppiK.PoeweW.2019Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations339905918https://doi.org/10.1007/s40263-019-00661-zSearch in Google Scholar
Eichel, H. V., Heine, J., Wegner, F., Rogozinski, S., Stiel, S., Groh, A., Krey, L., Höglinger, G. U., & Klietz, M. (2022). Neuropsychiatric Symptoms in Parkinson's Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden. Brain Sci, 12(1). https://doi.org/10.3390/brainsci12010089EichelH. V.HeineJ.WegnerF.RogozinskiS.StielS.GrohA.KreyL.HöglingerG. U.KlietzM.2022Neuropsychiatric Symptoms in Parkinson's Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden121https://doi.org/10.3390/brainsci12010089Search in Google Scholar
Foltynie, T., Magee, C., James, C., Webster, G. J. M., Lees, A. J., & Limousin, P. (2013). Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series. Parkinsons Dis, 2013, 362908–362905. https://doi.org/10.1155/2013/362908FoltynieT.MageeC.JamesC.WebsterG. J. M.LeesA. J.LimousinP.2013Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series2013362908362905https://doi.org/10.1155/2013/362908Search in Google Scholar
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez-Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang, A. E., Lees, A., Leurgans, S., LeWitt, P. A., Nyenhuis, D., Olanow, C. W., Rascol, O., Schrag, A., Teresi, J. A., van Hilten, J. J., & LaPelle, N. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord, 23(15), 2129–2170. https://doi.org/10.1002/mds.22340GoetzC. G.TilleyB. C.ShaftmanS. R.StebbinsG. T.FahnS.Martinez-MartinP.PoeweW.SampaioC.SternM. B.DodelR.DuboisB.HollowayR.JankovicJ.KulisevskyJ.LangA. E.LeesA.LeurgansS.LeWittP. A.NyenhuisD.OlanowC. W.RascolO.SchragA.TeresiJ. A.van HiltenJ. J.LaPelleN.2008Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results231521292170https://doi.org/10.1002/mds.22340Search in Google Scholar
Greenland, J. C., Williams-Gray, C. H., & Barker, R. A. (2019). The clinical heterogeneity of Parkinson's disease and its therapeutic implications. Eur J Neurosci, 49(3), 328–338. https://doi.org/10.1111/ejn.14094GreenlandJ. C.Williams-GrayC. H.BarkerR. A.2019The clinical heterogeneity of Parkinson's disease and its therapeutic implications493328338https://doi.org/10.1111/ejn.14094Search in Google Scholar
Grissinger, M. (2018). Delayed Administration and Contraindicated Drugs Place Hospitalized Parkinson's Disease Patients at Risk. P & T : a peer-reviewed journal for formulary management, 43(1), 10–39. https://pubmed.ncbi.nlm.nih.gov/29290668https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737245/GrissingerM.2018Delayed Administration and Contraindicated Drugs Place Hospitalized Parkinson's Disease Patients at Risk4311039https://pubmed.ncbi.nlm.nih.gov/29290668https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737245/Search in Google Scholar
Grover, S., Somaiya, M., Kumar, S., & Avasthi, A. (2015). Psychiatric aspects of Parkinson's disease. J Neurosci Rural Pract, 6(1), 65–76. https://doi.org/10.4103/0976-3147.143197GroverS.SomaiyaM.KumarS.AvasthiA.2015Psychiatric aspects of Parkinson's disease616576https://doi.org/10.4103/0976-3147.143197Search in Google Scholar
Hartmann, C. J., Fliegen, S., Groiss, S. J., Wojtecki, L., & Schnitzler, A. (2019). An update on best practice of deep brain stimulation in Parkinson's disease. Ther Adv Neurol Disord, 12, 1756286419838096–1756286419838096. https://doi.org/10.1177/1756286419838096HartmannC. J.FliegenS.GroissS. J.WojteckiL.SchnitzlerA.2019An update on best practice of deep brain stimulation in Parkinson's disease1217562864198380961756286419838096https://doi.org/10.1177/1756286419838096Search in Google Scholar
Hayes, M. W., Fung, V. S., Kimber, T. E., & O’Sullivan, J. D. (2010). Current concepts in the management of Parkinson disease. The Medical Journal of Australia, 192(3), 144–149.HayesM. W.FungV. S.KimberT. E.O’SullivanJ. D.2010Current concepts in the management of Parkinson disease1923144149Search in Google Scholar
Hung, A. Y., & Schwarzschild, M. A. (2014). Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline? Neurotherapeutics, 11(1), 34–46. https://doi.org/10.1007/s13311-013-0239-9HungA. Y.SchwarzschildM. A.2014Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?1113446https://doi.org/10.1007/s13311-013-0239-9Search in Google Scholar
Jose, A., Bhargavan, A., Appireddy, R., Raghunath, P., Rajan, R., & Iype, T. (2021). Neuropsychiatric Symptoms and Caregiver's Burden in Parkinson's Disease Patients in a Tertiary Care Teaching Hospital in South India: A Cross-Sectional Study. Neurology India, 69(6), 1706–1710. https://doi.org/10.4103/0028-3886.333437JoseA.BhargavanA.AppireddyR.RaghunathP.RajanR.IypeT.2021Neuropsychiatric Symptoms and Caregiver's Burden in Parkinson's Disease Patients in a Tertiary Care Teaching Hospital in South India: A Cross-Sectional Study69617061710https://doi.org/10.4103/0028-3886.333437Search in Google Scholar
Kaiserova, M., Grambalova, Z., Kurcova, S., Otruba, P., Prikrylova Vranova, H., Mensikova, K., & Kanovsky, P. (2021). Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 165(2), 103–112. https://doi.org/10.5507/bp.2021.002KaiserovaM.GrambalovaZ.KurcovaS.OtrubaP.Prikrylova VranovaH.MensikovaK.KanovskyP.2021Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods1652103112https://doi.org/10.5507/bp.2021.002Search in Google Scholar
Kujawska, M., & Jodynis-Liebert, J. (2018). What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut? Int J Mol Sci, 19(11). https://doi.org/10.3390/ijms19113573KujawskaM.Jodynis-LiebertJ.2018What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?1911https://doi.org/10.3390/ijms19113573Search in Google Scholar
Lee, T. K., & Yankee, E. L. (2021). A review on Parkinson's disease treatment. Neuroimmunology and Neuroinflammation, 8, 222. https://doi.org/10.20517/2347-8659.2020.58LeeT. K.YankeeE. L.2021A review on Parkinson's disease treatment8222https://doi.org/10.20517/2347-8659.2020.58Search in Google Scholar
Lees, A. (2017). An essay on the shaking palsy. Brain, 140(3), 843–848. https://doi.org/10.1093/brain/awx035LeesA.2017An essay on the shaking palsy1403843848https://doi.org/10.1093/brain/awx035Search in Google Scholar
Lo Buono, V., Palmeri, R., De Salvo, S., Berenati, M., Greco, A., Ciurleo, R., Sorbera, C., Cimino, V., Corallo, F., Bramanti, P., Marino, S., Di Lorenzo, G., & Bonanno, L. (2021). Anxiety, depression, and quality of life in Parkinson's disease: the implications of multidisciplinary treatment. Neural Regen Res, 16(3), 587–590. https://doi.org/10.4103/1673-5374.293151Lo BuonoV.PalmeriR.De SalvoS.BerenatiM.GrecoA.CiurleoR.SorberaC.CiminoV.CoralloF.BramantiP.MarinoS.Di LorenzoG.BonannoL.2021Anxiety, depression, and quality of life in Parkinson's disease: the implications of multidisciplinary treatment163587590https://doi.org/10.4103/1673-5374.293151Search in Google Scholar
Martini, A., Weis, L., Schifano, R., Pistonesi, F., Fiorenzato, E., Antonini, A., & Biundo, R. (2020). Differences in cognitive profiles between Lewy body and Parkinson's disease dementia. Journal of Neural Transmission, 127(3), 323–330. https://doi.org/10.1007/s00702-019-02129-2MartiniA.WeisL.SchifanoR.PistonesiF.FiorenzatoE.AntoniniA.BiundoR.2020Differences in cognitive profiles between Lewy body and Parkinson's disease dementia1273323330https://doi.org/10.1007/s00702-019-02129-2Search in Google Scholar
Mohamad, K. A., Wahdan, S. A., & Elnaga, R. N. (2021). Overview on Parkinson's disease: pathophysiology, and experimental models. Archives of Pharmaceutical Sciences Ain Shams University, 5(2), 212–224. https://doi.org/10.21608/aps.2021.92639.1068MohamadK. A.WahdanS. A.ElnagaR. N.2021Overview on Parkinson's disease: pathophysiology, and experimental models52212224https://doi.org/10.21608/aps.2021.92639.1068Search in Google Scholar
Nakmode, D. D., Day, C. M., Song, Y., & Garg, S. (2023). The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems. Pharmaceutics, 15(5). https://doi.org/10.3390/pharmaceutics15051503NakmodeD. D.DayC. M.SongY.GargS.2023The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems155https://doi.org/10.3390/pharmaceutics15051503Search in Google Scholar
Nolden, L. F., Tartavoulle, T., & Porche, D. J. (2014). Parkinson's Disease: Assessment, Diagnosis, and Management. Journal for nurse practitioners, 10(7), 500–506. https://doi.org/10.1016/j.nurpra.2014.04.019NoldenL. F.TartavoulleT.PorcheD. J.2014Parkinson's Disease: Assessment, Diagnosis, and Management107500506https://doi.org/10.1016/j.nurpra.2014.04.019Search in Google Scholar
Postuma, R. B., Berg, D., Adler, C. H., Bloem, B. R., Chan, P., Deuschl, G., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., Lang, A. E., Liepelt-Scarfone, I., Litvan, I., Marek, K., Oertel, W., Olanow, C. W., Poewe, W., & Stern, M. (2016). The new definition and diagnostic criteria of Parkinson's disease. Lancet Neurol, 15(6), 546–548. https://doi.org/10.1016/S1474-4422(16)00116-2PostumaR. B.BergD.AdlerC. H.BloemB. R.ChanP.DeuschlG.GasserT.GoetzC. G.HallidayG.JosephL.LangA. E.Liepelt-ScarfoneI.LitvanI.MarekK.OertelW.OlanowC. W.PoeweW.SternM.2016The new definition and diagnostic criteria of Parkinson's disease156546548https://doi.org/10.1016/S1474-4422(16)00116-2Search in Google Scholar
Rietdijk, C. D., Perez-Pardo, P., Garssen, J., van Wezel, R. J. A., & Kraneveld, A. D. (2017). Exploring Braak's Hypothesis of Parkinson's Disease [Review]. Frontiers in neurology, 8. https://doi.org/10.3389/fneur.2017.00037RietdijkC. D.Perez-PardoP.GarssenJ.van WezelR. J. A.KraneveldA. D.2017Exploring Braak's Hypothesis of Parkinson's Disease [Review]8https://doi.org/10.3389/fneur.2017.00037Search in Google Scholar
Rispoli, V., Simioni, V., Capone, J. G., Golfrè Andreasi, N., Preda, F., Sette, E., Tugnoli, V., & Sensi, M. (2017). Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation. Acta Neurol Scand, 136(6), 660–667. https://doi.org/10.1111/ane.12783RispoliV.SimioniV.CaponeJ. G.Golfrè AndreasiN.PredaF.SetteE.TugnoliV.SensiM.2017Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation1366660667https://doi.org/10.1111/ane.12783Search in Google Scholar
Samson, E., & Noseworthy, M. D. (2022). A review of diagnostic imaging approaches to assessing Parkinson's disease. Brain Disorders, 6, 100037. https://doi.org/https://doi.org/10.1016/j.dscb.2022.100037SamsonE.NoseworthyM. D.2022A review of diagnostic imaging approaches to assessing Parkinson's disease6100037https://doi.org/https://doi.org/10.1016/j.dscb.2022.100037Search in Google Scholar
Simioni, V., Sette, E., Capone, J. G., Preda, F., Granieri, E., Sensi, M., & Tugnoli, V. (2016). 50. Peripheral neuropathy associated with Duodopa infusion: neurophysiological retrospective study. Clinical neurophysiology, 127(12), e335–e335. https://doi.org/10.1016/j.clinph.2016.10.062SimioniV.SetteE.CaponeJ. G.PredaF.GranieriE.SensiM.TugnoliV.201650. Peripheral neuropathy associated with Duodopa infusion: neurophysiological retrospective study12712e335e335https://doi.org/10.1016/j.clinph.2016.10.062Search in Google Scholar
Spliethoff-Kamminga, N. G. A., Zwinderman, A. H., Springer, M. P., & Roos, R. A. C. (2003). A disease-specific psychosocial questionnaire for Parkinson's disease caregivers. J Neurol, 250(10), 1162–1168. https://doi.org/10.1007/s00415-003-0165-6Spliethoff-KammingaN. G. A.ZwindermanA. H.SpringerM. P.RoosR. A. C.2003A disease-specific psychosocial questionnaire for Parkinson's disease caregivers2501011621168https://doi.org/10.1007/s00415-003-0165-6Search in Google Scholar
Taki, S., Maekita, T., Sakata, M., Fukatsu, K., Maeda, Y., Iguchi, M., Ito, H., & Kitano, M. (2019). Migration of a percutaneous endoscopic gastrojejunostomy tube into the colon with small intestinal telescoping. Clin Endosc, 52(6), 616–619. https://doi.org/10.5946/ce.2019.016TakiS.MaekitaT.SakataM.FukatsuK.MaedaY.IguchiM.ItoH.KitanoM.2019Migration of a percutaneous endoscopic gastrojejunostomy tube into the colon with small intestinal telescoping526616619https://doi.org/10.5946/ce.2019.016Search in Google Scholar
Tsui, D. S.-Y. (2014). The Tomorrow: Advanced Treatments in Parkinson's Disease Does Not Necessarily Equate to Treatments in Advanced Parkinson's Disease Australasian Journal of Neuroscience, 24(2), 34–37.TsuiD. S.-Y.2014The Tomorrow: Advanced Treatments in Parkinson's Disease Does Not Necessarily Equate to Treatments in Advanced Parkinson's Disease2423437Search in Google Scholar
Tysnes, O.-B., & Storstein, A. (2017). Epidemiology of Parkinson's disease. Journal of Neural Transmission, 124(8), 901–905. https://doi.org/10.1007/s00702-017-1686-yTysnesO.-B.StorsteinA.2017Epidemiology of Parkinson's disease1248901905https://doi.org/10.1007/s00702-017-1686-ySearch in Google Scholar
Waller, S., Williams, L., Morales-Briceño, H., & Fung, V. (2021). The initial diagnosis and management of Parkinson's disease. Australian Journal for General Practitioners, 50, 793–800. https://www1.racgp.org.au/ajgp/2021/november/diagnosis-and-management-of-parkinsonsWallerS.WilliamsL.Morales-BriceñoH.FungV.2021The initial diagnosis and management of Parkinson's disease50793800https://www1.racgp.org.au/ajgp/2021/november/diagnosis-and-management-of-parkinsonsSearch in Google Scholar
Xu, Z., Anderson, K. N., Saffari, S. E., Lawson, R. A., Chaudhuri, K. R., Brooks, D., & Pavese, N. (2021). Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study. J Neurol, 268(1), 312–320. https://doi.org/10.1007/s00415-020-10140-xXuZ.AndersonK. N.SaffariS. E.LawsonR. A.ChaudhuriK. R.BrooksD.PaveseN.2021Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study2681312320https://doi.org/10.1007/s00415-020-10140-xSearch in Google Scholar
Yi, Q., Yu-Peng, C., Jiang-Ting, L., Jing-Yi, L., Qi-Xiong, Q., Dan-Lei, W., Jing-Wei, Z., Zhi-Juan, M., Yong-Jie, X., Zhe, M., & Zheng, X. (2022). Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease. Front Aging Neurosci, 14, 887094. https://doi.org/10.3389/fnagi.2022.887094YiQ.Yu-PengC.Jiang-TingL.Jing-YiL.Qi-XiongQ.Dan-LeiW.Jing-WeiZ.Zhi-JuanM.Yong-JieX.ZheM.ZhengX.2022Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease14887094https://doi.org/10.3389/fnagi.2022.887094Search in Google Scholar